Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
22.96
-0.43 (-1.84%)
At close: Apr 28, 2026, 4:00 PM EDT
22.96
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT

Company Description

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors.

It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program.

The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022.

Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Pediatrix Medical Group, Inc.
Pediatrix Medical Group logo
Country United States
Founded 1979
IPO Date Sep 19, 1995
Industry Medical Care Facilities
Sector Healthcare
Employees 4,280
CEO Mark Ordan

Contact Details

Address:
1301 Concord Terrace
Sunrise, Florida 33323
United States
Phone 954 384 0175
Website pediatrix.com

Stock Details

Ticker Symbol MD
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000893949
CUSIP Number 58502B106
ISIN Number US58502B1061
Employer ID 26-3667538
SIC Code 8060

Key Executives

Name Position
Mark S. Ordan Chief Executive Officer and Executive Chairman
Kasandra H. Rossi Executive Vice President, Treasurer and Chief Financial Officer
D. Gregory Neeb Executive Vice President and Chief Investment and Strategy Officer
Mary Ann E. Moore J.D. Chief Administrative Officer, Executive Vice President, General Counsel and Secretary
Nanette Sanders Executive Vice President of National Operations
John C. Pepia Senior Vice President and Chief Accounting Officer
Cheryl M. VanPatten Senior Vice President and Chief Information Officer
Debra McRoberts Senior Vice President of People Services
Kevin Pitzer President of West Division
Mike Ashford President of South Central Division

Latest SEC Filings

Date Type Title
Apr 17, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 27, 2026 ARS Filing
Mar 27, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 27, 2026 DEF 14A Other definitive proxy statements
Feb 19, 2026 10-K Annual Report
Feb 19, 2026 8-K Current Report
Dec 15, 2025 144 Filing
Nov 17, 2025 144 Filing
Nov 6, 2025 144 Filing
Nov 3, 2025 10-Q Quarterly Report